Citrus Sinensis ID: 040040


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------87
SPFLALTTITRALKNKSVPEWENVLQELQRPSMKNFQGVLKEACSTIELHYKYLKGEKLKKIFLLCSCHDPTQTCHDIRDSACPLKRCLDKPQEKTNDISLKLNASICLKDKFFTQLKGLEELWLDEVQGVENVVYELDREGFPSLKLLHIQNNPYLLCINDSTELVPRDAFPLLESLSLSNLMNLEKISCSQLRAESFLRLRNLKVESCEKLTHIFSFSISRGLPQLQTIKVTACKNMKVIFEVGREDDINNTEVIDKIEFSQLRKLTLKSLPQLRSFCSVVAFPNLETLKLSAINSETIWHNQLPAMSSCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRKCMDLEGIVFPEEMIEEERKDIVFPQLNFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKCPELKAFILQNINTDMTVVGIQSFFNEKSFCKLKLMEVIFCKSLWTIFPHNMFARFLKLQSLIVGACGSLEEIFNLQELNSEETHSGAVSRLRELHVFCLPKLTKIWNKDPRGKLIFPNLVLVRIFECQRLKSIFPTSVEIVANDVRGNDAATKFIFPSLTFLKLRDLPYLTTFYSGMHTLECPERANLIFQLKNPSFGSKSLVMLLCLIGQQVFPNLEELTLSKYIFTTWRQAQFHKLKILHFISDGSDFFQVGLLQNIHNLEKLVLKVEEHAEGIAQIKSLKLNKLWFIKEHLWNPDSKLDSFLQNLEFLEVKECALSLISLRIEIVFSKLKWLFLESSGSITSFCSGNYAISFPSLEVLIVENCPKLNTFSAGVLKTPRLRAVQNWKLDEDFWAGDVNTTLQHLNEKMAKRRMTEVEYESETSMSEENEAEEEEENVGGDPSVCLRFILFNFHINDVLF
ccccHHHHHHHHHccccHHHHHHHHHHHccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccccccccccccccccccEEEcccccccccccccccccccEEEEccccccEEccccccccccccccEEEEEcccccEEEccccccccccccccccEEEEEccccccccccccccccccccccEEEEEEccccccccccccccccccccEEEEEEccccEEEccccccccccccccccccccccccEEEEcccccccccccccccccccEEEcccccccccccccccccccccccccEEEEEcccccccccccccccccccccEEEEEccccccccccccccccccccccccccccEEEEcccccccccccccccccccccEEEEEcccccccccccccccccccccccccccccccccccEEEEEEcccccccccHHHHcccccccEEEEEccccccEEccccccccccccccccccccEEEEccccccccccccccccccccccccEEEEEccccccEEcccccEEEEccccccccccccccccccEEEEcccccccccccccccccccccccHHcccccccccccHHHHHHHccccccccccccccccccccccccccccccccEEEEcccccccccHHHHcccccccEEEccccccccccccccEEEccccccccccccccccccccccccccEEEEEcccccccccccccccccccEEEcccccccccccccccccccccccEEEEEcccccccccccccccccccEEEEcccccccccccHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHcccccccEEEEEEEEEEEcccccc
ccHHHHHHHHHHHccccHHHHHHHHHHHHHccccccccccccEEEEEEEEHHccccHHHHHHHHHHHHcccHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHcccccccccEEEEcccccHHEEcccccccccccccccccEEcHccHHccHHcccccccHHHHHcccEEEEcccccccccccHHHHHHHHHccEEEEcccccHHEEEcccccccccccccccccccccccEEEEcccccccccccHcccccccEEEEEEcccccHHccccccccccccccEEEEEccccccHHcccHHHHHHHHHHcEEEEcccccHEEEEcccccccccccEEEccccEEEEEcccccccEcccccccccccccEEEEEccccccEEccHHHHHHccccccccccccccccccEEEEEccccccEEcccHHHHHHHHHccEEEEcccccEEEEEcccccccccccccccccccEEEEcccccHHHHcccccccccEccccEEEEEEccccHHHcccccEEEEEccccccEEEEEEEcccccEEEEcccccccEccccccccccccHcEEEEEcccccccccccccccccccccccccHHHcccccccccHHHHHHHHcccEEEEEcccccHHcHccHHccccHHHHHcccccccccccccccEEEEcHHHHHHHEccccHHHHHHcccccEEEEcccHHHHEHHHHHHHcccccEEEEcccccccEccccccccccccccEEEEEcccccEEEccccccccccEEEEEcccccHHccccHHHHHHHHHHHHcccccccEEHccccccccccccccccccccccccEEEEEEEEcccHcHEcc
SPFLALTTITRALKNKSVPEWENVLQELQRPSMKNFQGVLKEACSTIELHYKYLKGEKLKKIFLLCschdptqtchdirdsacplkrcldkpqektndisLKLNASICLKDKFFTQLKGLEELWLDEVQGVENVVYEldregfpslkllhiqnnpyllcindstelvprdafplleslslsnlmnlekiSCSQLRAESFLRLRNLKVESCEKLTHIFSFsisrglpqlqTIKVTACKNMKVIFEVgreddinntevIDKIEFSQLRKLTLKslpqlrsfcsvvafpnletlklsainsetiwhnqlpamssCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRKcmdlegivfpeemieeerkdivfpqlnflkmkDLAKLTRFcsgncielpslkqlrmaKCPELKAFILQNINTDMTVVGIQSFFNEKSFCKLKLMEVIFCKSLWTIFPHNMFARFLKLQSLIVGACGSLeeifnlqelnseethSGAVSRLRELHVFClpkltkiwnkdprgklifpnLVLVRIFECqrlksifptSVEIVAndvrgndaatkfifpsltflklrdlpylttfysgmhtlecperANLIfqlknpsfgsKSLVMLLCLIgqqvfpnleeltLSKYIFTTWRQAQFHKLKILHFisdgsdffqVGLLQNIHNLEKLVLKVEEHAEGIAQIKSLKLNKLWFIKEhlwnpdskldSFLQNLEFLEVKECALSLISLRIEIVFSKLKWLFlessgsitsfcsgnyaisfpslevlivencpklntfsagvlktprlrAVQNWkldedfwagdVNTTLQHLNEKMAKRRMTEVEYesetsmseeneaeeeeenvggdpsvCLRFILFNfhindvlf
spflalttitralknksvpeWENVLQELQRPSMKNFQGVLKEACSTIELHYKYLKGEKLKKIFLLCSCHDPTQTCHDIRDSACPLKRCLDKPQEKTNDISLKLNASICLKDKFFTQLKGLEELWLDEVQGVENVVYELDREGFPSLKLLHIQNNPYLLCINDSTELVPRDAFPLLESLSLSNLMNLEKISCSQLRAESFLRLRNLKVESCEKLTHIfsfsisrglpqLQTIKVTACKNMKVIFevgreddinntEVIDKIEFSQLRKLTLKSLPQLRSFCSVVAFPNLETLKLSAINSETIWHNQLPAMSSCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRKCMDLEGIVFPEEMIEEERKDIVFPQLNFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKCPELKAFILQNINTDMTVVGIQSFFNEKSFCKLKLMEVIFCKSLWTIFPHNMFARFLKLQSLIVGACGSLEEIFNLQELNSEETHSGAVSRLRELHVFCLPkltkiwnkdprgkLIFPNLVLVRIFECQRLKSIFPTSVEIVANDVRGNDAATkfifpsltflklRDLPYLTTFYSGMHTLECPERANLIFQLKNPSFGSKSLVMLLCLIGQQVFPNLEELTLSKYIFTTWRQAQFHKLKILHFISDGSDFFQVGLLQNIHNLEKLVLKVEEHAEGIAQIKSLKLNKLWFIKEHLWNPDSKLDSFLQNLEFLEVKECALSLISLRIEIVFSKLKWLFLESSGSITSFCSGNYAISFPSLEVLIVENCPKLNtfsagvlktprLRAVQNWKLDEDFWAGDVNTTLQHLNEKMAKRRMTEVEYEsetsmseeneaEEEEENVGGDPSVCLRFILFNFHINDVLF
SPFLALTTITRALKNKSVPEWENVLQELQRPSMKNFQGVLKEACSTIELHYKYLKGEKLKKIFLLCSCHDPTQTCHDIRDSACPLKRCLDKPQEKTNDISLKLNASICLKDKFFTQLKGLEELWLDEVQGVENVVYELDREGFPSLKLLHIQNNPYLLCINDSTELVPRDAFPlleslslsnlmnleKISCSQLRAESFLRLRNLKVESCEKLTHIFSFSISRGLPQLQTIKVTACKNMKVIFEVGREDDINNTEVIDKIEFSQLRKLTLKSLPQLRSFCSVVAFPNLETLKLSAINSETIWHNQLPAMSSCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRKCMDLEGIVFPEEMIEEERKDIVFPQLNFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKCPELKAFILQNINTDMTVVGIQSFFNEKSFCKLKLMEVIFCKSLWTIFPHNMFARFLKLQSLIVGACGSLEEIFNLQELNSEETHSGAVSRLRELHVFCLPKLTKIWNKDPRGKLIFPNLVLVRIFECQRLKSIFPTSVEIVANDVRGNDAATKFIFPSLTFLKLRDLPYLTTFYSGMHTLECPERANLIFQLKNPSFGSKSLVMLLCLIGQQVFPNLEELTLSKYIFTTWRQAQFHKLKILHFISDGSDFFQVGLLQNIHNLEKLVLKVEEHAEGIAQIKSLKLNKLWFIKEHLWNPDSKLDSFLQNLEFLEVKECALSLISLRIEIVFSKLKWLFLESSGSITSFCSGNYAISFPSLEVLIVENCPKLNTFSAGVLKTPRLRAVQNWKLDEDFWAGDVNTTLQHLNEKMAKRRMTeveyesetsmseeneaeeeeeNVGGDPSVCLRFILFNFHINDVLF
***LALTTITRALKNKSVPEWENVLQELQRPSMKNFQGVLKEACSTIELHYKYLKGEKLKKIFLLCSCHDPTQTCHDIRDSACPLKRCLDKPQEKTNDISLKLNASICLKDKFFTQLKGLEELWLDEVQGVENVVYELDREGFPSLKLLHIQNNPYLLCINDSTELVPRDAFPLLESLSLSNLMNLEKISCSQLRAESFLRLRNLKVESCEKLTHIFSFSISRGLPQLQTIKVTACKNMKVIFEVGREDDINNTEVIDKIEFSQLRKLTLKSLPQLRSFCSVVAFPNLETLKLSAINSETIWHNQLPAMSSCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRKCMDLEGIVFPEEMIEEERKDIVFPQLNFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKCPELKAFILQNINTDMTVVGIQSFFNEKSFCKLKLMEVIFCKSLWTIFPHNMFARFLKLQSLIVGACGSLEEIFNLQELNSEETHSGAVSRLRELHVFCLPKLTKIWNKDPRGKLIFPNLVLVRIFECQRLKSIFPTSVEIVANDVRGNDAATKFIFPSLTFLKLRDLPYLTTFYSGMHTLECPERANLIFQLKNPSFGSKSLVMLLCLIGQQVFPNLEELTLSKYIFTTWRQAQFHKLKILHFISDGSDFFQVGLLQNIHNLEKLVLKVEEHAEGIAQIKSLKLNKLWFIKEHLWNPDSKLDSFLQNLEFLEVKECALSLISLRIEIVFSKLKWLFLESSGSITSFCSGNYAISFPSLEVLIVENCPKLNTFSAGVLKTPRLRAVQNWKLDEDFWAGDVNTTLQHL*******************************************************
SPFLALTTITRALKNKSVPEWENVLQELQRPS*****GVLKEACSTIELHYKYLKGEKLKKIFLLCSCHDPTQTCHDIRDSACPLKRCLDKPQEKTNDISLKLNASICLKDKFFTQLKGLEELWLDEVQGVENVVYELDREGFPSLKLLHIQNNPYLLCINDSTELVPRDAFPLLESLSLSNLMNLEKISCSQLRAESFLRLRNLKVESCEKLTHIFSFSISRGLPQLQTIKVTACKNMKVIFEVG************KIEFSQLRKLTLKSLPQLRSFCSVVAFPNLETLKLSAINSETIWHNQLPAMSSCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRKCMDLEGIVF************VFPQLNFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKCPELKAFILQNINTDMTVVGIQSFFNEKSFCKLKLMEVIFCKSLWTIFPHNMFARFLKLQSLIVGACGSLEEIFNLQE********GAVSRLRELHVFCLPKLTKIWNKDPRGKLIFPNLVLVRIFECQRLKSIFPTSVEIVANDVRGNDAATKFIFPSLTFLKLRDLPYLTTFYSGMHTLECPERANLIFQLKNPSFGSKSLVMLLCLIGQQVFPNLEELTLSKYIFTTWRQAQFHKLKILHFISDGSDFFQVGLLQNIHNLEKLVLKVEEHAEGIAQIKSLKLNKLWFIKEHLWNPDSKLDSFLQNLEFLEVKECA***********F**LKWLFLESSGSITSFCSGNYAISFPSLEVLIVENCPKLNTFSAGVLKTPRLRAVQNWKLDEDFWAGDVNTTLQHLNEKMAKRRMTEV*********************GGDPSVCLRFILFNFHINDVLF
SPFLALTTITRALKNKSVPEWENVLQELQRPSMKNFQGVLKEACSTIELHYKYLKGEKLKKIFLLCSCHDPTQTCHDIRDSACPLKRCLDKPQEKTNDISLKLNASICLKDKFFTQLKGLEELWLDEVQGVENVVYELDREGFPSLKLLHIQNNPYLLCINDSTELVPRDAFPLLESLSLSNLMNLEKISCSQLRAESFLRLRNLKVESCEKLTHIFSFSISRGLPQLQTIKVTACKNMKVIFEVGREDDINNTEVIDKIEFSQLRKLTLKSLPQLRSFCSVVAFPNLETLKLSAINSETIWHNQLPAMSSCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRKCMDLEGIVFPEEMIEEERKDIVFPQLNFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKCPELKAFILQNINTDMTVVGIQSFFNEKSFCKLKLMEVIFCKSLWTIFPHNMFARFLKLQSLIVGACGSLEEIFNLQELN********VSRLRELHVFCLPKLTKIWNKDPRGKLIFPNLVLVRIFECQRLKSIFPTSVEIVANDVRGNDAATKFIFPSLTFLKLRDLPYLTTFYSGMHTLECPERANLIFQLKNPSFGSKSLVMLLCLIGQQVFPNLEELTLSKYIFTTWRQAQFHKLKILHFISDGSDFFQVGLLQNIHNLEKLVLKVEEHAEGIAQIKSLKLNKLWFIKEHLWNPDSKLDSFLQNLEFLEVKECALSLISLRIEIVFSKLKWLFLESSGSITSFCSGNYAISFPSLEVLIVENCPKLNTFSAGVLKTPRLRAVQNWKLDEDFWAGDVNTTLQHLNEKMAKR***************************GDPSVCLRFILFNFHINDVLF
SPFLALTTITRALKNKSVPEWENVLQELQRPSMKNFQGVLKEACSTIELHYKYLKGEKLKKIFLLCSCHDPTQTCHDIRDSACPLKRCLDKPQEKTNDISLKLNASICLKDKFFTQLKGLEELWLDEVQGVENVVYELDREGFPSLKLLHIQNNPYLLCINDSTELVPRDAFPLLESLSLSNLMNLEKISCSQLRAESFLRLRNLKVESCEKLTHIFSFSISRGLPQLQTIKVTACKNMKVIFEVGREDDINNTEVIDKIEFSQLRKLTLKSLPQLRSFCSVVAFPNLETLKLSAINSETIWHNQLPAMSSCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRKCMDLEGIVFPEEMIEEERKDIVFPQLNFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKCPELKAFILQNINTDMTVVGIQSFFNEKSFCKLKLMEVIFCKSLWTIFPHNMFARFLKLQSLIVGACGSLEEIFNLQELNSEETHSGAVSRLRELHVFCLPKLTKIWNKDPRGKLIFPNLVLVRIFECQRLKSIFPTSVEIVANDVRGNDAATKFIFPSLTFLKLRDLPYLTTFYSGMHTLECPERANLIFQLKNPSFGSKSLVMLLCLIGQQVFPNLEELTLSKYIFTTWRQAQFHKLKILHFISDGSDFFQVGLLQNIHNLEKLVLKVEEHAEGIAQIKSLKLNKLWFIKEHLWNPDSKLDSFLQNLEFLEVKECALSLISLRIEIVFSKLKWLFLESSGSITSFCSGNYAISFPSLEVLIVENCPKLNTFSAGVLKTPRLRAVQNWKLDEDFWAGDVNTTLQHLNEKMAKRRMTEVEYE*****************VGGDPSVCLRFILFNFHINDVLF
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
SPFLALTTITRALKNKSVPEWENVLQELQRPSMKNFQGVLKEACSTIELHYKYLKGEKLKKIFLLCSCHDPTQTCHDIRDSACPLKRCLDKPQEKTNDISLKLNASICLKDKFFTQLKGLEELWLDEVQGVENVVYELDREGFPSLKLLHIQNNPYLLCINDSTELVPRDAFPLLESLSLSNLMNLEKISCSQLRAESFLRLRNLKVESCEKLTHIFSFSISRGLPQLQTIKVTACKNMKVIFEVGREDDINNTEVIDKIEFSQLRKLTLKSLPQLRSFCSVVAFPNLETLKLSAINSETIWHNQLPAMSSCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRKCMDLEGIVFPEEMIEEERKDIVFPQLNFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKCPELKAFILQNINTDMTVVGIQSFFNEKSFCKLKLMEVIFCKSLWTIFPHNMFARFLKLQSLIVGACGSLEEIFNLQELNSEETHSGAVSRLRELHVFCLPKLTKIWNKDPRGKLIFPNLVLVRIFECQRLKSIFPTSVEIVANDVRGNDAATKFIFPSLTFLKLRDLPYLTTFYSGMHTLECPERANLIFQLKNPSFGSKSLVMLLCLIGQQVFPNLEELTLSKYIFTTWRQAQFHKLKILHFISDGSDFFQVGLLQNIHNLEKLVLKVEEHAEGIAQIKSLKLNKLWFIKEHLWNPDSKLDSFLQNLEFLEVKECALSLISLRIEIVFSKLKWLFLESSGSITSFCSGNYAISFPSLEVLIVENCPKLNTFSAGVLKTPRLRAVQNWKLDEDFWAGDVNTTLQHLNEKMAKRRMTEVEYESETSMSEENEAEEEEENVGGDPSVCLRFILFNFHINDVLF
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query869 2.2.26 [Sep-21-2011]
O81825919 Probable disease resistan yes no 0.235 0.223 0.276 2e-07
>sp|O81825|DRL28_ARATH Probable disease resistance protein At4g27220 OS=Arabidopsis thaliana GN=At4g27220 PE=2 SV=1 Back     alignment and function desciption
 Score = 58.5 bits (140), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 19/224 (8%)

Query: 208 ESCEKLTHIFSFSISRG--LPQLQTIKVTACKNMKVIFEVGREDDINNTEVIDKIEFSQL 265
           E C  ++ +   + S G  L  + ++ +  C+ +  +FE        N     K  F  +
Sbjct: 692 EGCLAISDVNVSNASIGWLLQHVTSLDLNYCEGLNGMFE--------NLVTKSKSSFVAM 743

Query: 266 RKLTLKSLPQLR--SFC--SVVAFPNLETLKLSAINSETIWH-NQLPAMSSCIQNLTRLI 320
           + L++   P L   S C   +  FPNLE L L  +N E+I   N    M   +Q L  L 
Sbjct: 744 KALSIHYFPSLSLASGCESQLDLFPNLEELSLDNVNLESIGELNGFLGMR--LQKLKLLQ 801

Query: 321 VHGCNNLKFLFSTS-LVRSFVQLQHLEIRKCMDLEGIVFPEEMIEEERKDIVFPQLNFLK 379
           V GC  LK LFS   L  +   LQ +++  C+ LE +     +  +   + + P+L  +K
Sbjct: 802 VSGCRQLKRLFSDQILAGTLPNLQEIKVVSCLRLEELFNFSSVPVDFCAESLLPKLTVIK 861

Query: 380 MKDLAKLTRFCSGNCIELPSLKQLRMAKCPELKAFILQNINTDM 423
           +K L +L   C+   + L SL+ L +  C  LK       NT M
Sbjct: 862 LKYLPQLRSLCNDRVV-LESLEHLEVESCESLKNLPFVPGNTGM 904




Probable disease resistance protein.
Arabidopsis thaliana (taxid: 3702)

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query869
224110992 2359 cc-nbs-lrr resistance protein [Populus t 0.834 0.307 0.316 1e-103
255542484 2460 phosphoprotein phosphatase, putative [Ri 0.823 0.291 0.339 3e-95
224111296 1315 cc-nbs-lrr resistance protein [Populus t 0.563 0.372 0.394 7e-95
224143316 1337 cc-nbs-lrr resistance protein [Populus t 0.562 0.365 0.393 2e-93
224111284 1340 cc-nbs-lrr resistance protein [Populus t 0.563 0.365 0.388 4e-92
255563252 1603 Disease resistance protein RPS5, putativ 0.540 0.293 0.391 1e-90
359488027 1520 PREDICTED: disease resistance protein At 0.797 0.455 0.336 5e-82
147802546 1409 hypothetical protein VITISV_007222 [Viti 0.792 0.488 0.320 7e-78
147787802 1517 hypothetical protein VITISV_005047 [Viti 0.745 0.427 0.312 2e-75
358344903 2248 Cc-nbs-lrr resistance protein [Medicago 0.762 0.294 0.305 9e-72
>gi|224110992|ref|XP_002332999.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222834484|gb|EEE72961.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
 Score =  383 bits (983), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 304/960 (31%), Positives = 443/960 (46%), Gaps = 235/960 (24%)

Query: 90   DKPQEKTNDISLKLNASICLKDKFFTQL-KGLEELWLDEVQGVENVVYELDREGFPSLKL 148
            D   E      LKLN  I  ++     L    E+L+L E++GV N++ ELDREGFP LK 
Sbjct: 702  DGAYEMLRTAKLKLNTKIDHRNYGIRMLLNRTEDLYLFEIEGV-NIIQELDREGFPHLKH 760

Query: 149  LHIQNNPYLLCINDSTELVPRDAFPLLESLSLSNLMNLEKISCSQLRAESFLRLRNLKVE 208
            L ++N+  +  I  + E+V  +AFP+LESL L +L +L+KI    LR ESF +LR + VE
Sbjct: 761  LQLRNSFEIQYIISTMEMVSSNAFPILESLILYDLSSLKKICHGALRVESFAKLRIIAVE 820

Query: 209  SCEKLTHIFSFSISRGLPQLQTIKVTACKNMKVIFEVGREDDINNTEVIDKIEFSQLRKL 268
             C KLT++FSF ++RGL QLQ IK+  C  M+ +     ++  +  EV+D I+F+QL  L
Sbjct: 821  HCNKLTNLFSFFVARGLSQLQKIKIAFCMKMEEVVAEESDELGDQNEVVDVIQFTQLYSL 880

Query: 269  TLKSLPQLRSFCSVVA---------------------------------------FPNLE 289
            +L+ LP L +F S V                                        FPNLE
Sbjct: 881  SLQYLPHLMNFYSKVKPSSLSRTQPKPSITEARSEEIISEDELRTPTQLFNEKILFPNLE 940

Query: 290  TLKLSAINSETIWHNQLPAMSSCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRK 349
             L L AIN + +W++Q P++S  IQNL RL+V+ C +LK+LF +SLV   VQL+HL I  
Sbjct: 941  DLNLYAINIDKLWNDQHPSISVSIQNLQRLVVNQCGSLKYLFPSSLVNILVQLKHLSITN 1000

Query: 350  CMDLEGIVFPEEMIEEERKDIVFPQLNFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKCP 409
            CM +E I+    + EEE    VFP+L F+++ DL KL RFC G+ IE P LK++R+  CP
Sbjct: 1001 CMSVEEIIAIGGLKEEETTSTVFPKLEFMELSDLPKLRRFCIGSSIECPLLKRMRICACP 1060

Query: 410  ELKAFILQ----NINTDMTVVG----------IQSFFNEK-------------------- 435
            E K F       NIN    +            IQS F EK                    
Sbjct: 1061 EFKTFAADFSCANINDGNELEEVNSEENNNNVIQSLFGEKCLNSLRLSNQGGLMQKFVSV 1120

Query: 436  ---------------------------SFCKLKLMEVIFCKSLWTIFPHNMFARFLKLQS 468
                                       SFC+L+ +++  CK +  IFP  +   F++L+ 
Sbjct: 1121 IFPSLAEIEISHIDNLEKIWHNNLAAGSFCELRSIKIRGCKKIVNIFPSVLIRSFMRLEV 1180

Query: 469  LIVGACGSLEEIFNLQELNSEETHSGAVSRLRELHVFCLPKLTKIWNKDPRGKLIFPNLV 528
            L +G C  LE IF+L+  + +E    +V +LR+L +  LPKL  IWNKDP+GK  F NL 
Sbjct: 1181 LEIGFCDLLEAIFDLKGPSVDEIQPSSVVQLRDLSLNSLPKLKHIWNKDPQGKHKFHNLQ 1240

Query: 529  LVRIFECQRLKSIFPTSV------------------EIVANDVRGNDAATKFIFPSLTFL 570
            +VR F C  LK++FP S+                  +IVA +  G +A   F+FP LT L
Sbjct: 1241 IVRAFSCGVLKNLFPFSIARVLRQLEKLEIVHCGVEQIVAKE-EGGEAFPYFMFPRLTSL 1299

Query: 571  KLRDLPYLTTFYSGMHTLECPERANL-IFQLKNPSFGSKSLVMLLCLIG----------- 618
             L ++     FY G HT ECP   +L +    N  +     + L  + G           
Sbjct: 1300 DLIEIRKFRNFYPGKHTWECPRLKSLAVSGCGNIKYFDSKFLYLQEVQGEIDPTVPIQQP 1359

Query: 619  ----QQVFPNLEELTL------SKYIFTTWRQAQFH-KLKILHF--ISDGSDFFQVGLLQ 665
                +++  NLEEL+L      +  I+      +F+ +LK++         D    G LQ
Sbjct: 1360 LFSDEEIISNLEELSLNGEDPATSIIWCCQFPGKFYSRLKVIKLKNFYGKLDPIPFGFLQ 1419

Query: 666  NIHNLEKLVLKV-------------------------EEHAEGIAQIKSLKLNKLWFIKE 700
            +I NLE L +                           +E+    A++K+L ++ +  I  
Sbjct: 1420 SIRNLETLSVSCSSFEKIFLNEGCVDKDEDIRGPVDSDEYTRMRARLKNLVIDSVQDIT- 1478

Query: 701  HLWNPDSKLDSFLQNLEFLEVKECALSLISLRIEIV-FSKLKWLFLESSGSITSFCSGNY 759
            H+W P  +L S +QNLE L+++ C  SL++L    V F  L+ L + S   +++  + + 
Sbjct: 1479 HIWEPKYRLISVVQNLESLKMQSCN-SLVNLAPSTVLFHNLETLDVHSCHGLSNLLTSST 1537

Query: 760  A-------------------------------ISFPSLEVL------------------- 769
            A                               I F  LE L                   
Sbjct: 1538 AKSLGQLVKLIVVNCKLVTEIVAKQGGEINDDIIFSKLEYLELVRLENLTSFCPGNYNFI 1597

Query: 770  -------IVENCPKLNTFSAGVLKTPRLRAVQNWKLD---EDFWAGDVNTTLQHLNEKMA 819
                   +VE CPK+  FS G+  TP+L+ V  WK D   E  W G++N TLQ L  KM 
Sbjct: 1598 FPSLKGMVVEQCPKMRIFSQGISSTPKLQGVY-WKKDSMNEKCWHGNLNATLQQLYTKMV 1656




Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542484|ref|XP_002512305.1| phosphoprotein phosphatase, putative [Ricinus communis] gi|223548266|gb|EEF49757.1| phosphoprotein phosphatase, putative [Ricinus communis] Back     alignment and taxonomy information
>gi|224111296|ref|XP_002332952.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222834264|gb|EEE72741.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|224143316|ref|XP_002336027.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222838884|gb|EEE77235.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|224111284|ref|XP_002332949.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222834261|gb|EEE72738.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|255563252|ref|XP_002522629.1| Disease resistance protein RPS5, putative [Ricinus communis] gi|223538105|gb|EEF39716.1| Disease resistance protein RPS5, putative [Ricinus communis] Back     alignment and taxonomy information
>gi|359488027|ref|XP_002269288.2| PREDICTED: disease resistance protein At4g27190-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|147802546|emb|CAN77665.1| hypothetical protein VITISV_007222 [Vitis vinifera] Back     alignment and taxonomy information
>gi|147787802|emb|CAN71755.1| hypothetical protein VITISV_005047 [Vitis vinifera] Back     alignment and taxonomy information
>gi|358344903|ref|XP_003636525.1| Cc-nbs-lrr resistance protein [Medicago truncatula] gi|355502460|gb|AES83663.1| Cc-nbs-lrr resistance protein [Medicago truncatula] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query869
TAIR|locus:2131689919 AT4G27220 [Arabidopsis thalian 0.235 0.223 0.272 1.8e-07
TAIR|locus:2201996889 RPS5 "AT1G12220" [Arabidopsis 0.295 0.289 0.25 2.2e-07
TAIR|locus:2005517909 RPS2 "RESISTANT TO P. SYRINGAE 0.177 0.169 0.257 1.3e-06
TAIR|locus:2034765884 AT1G12290 [Arabidopsis thalian 0.323 0.317 0.225 0.00023
TAIR|locus:2197739762 AT1G61300 [Arabidopsis thalian 0.113 0.129 0.289 0.00067
TAIR|locus:2131689 AT4G27220 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 164 (62.8 bits), Expect = 1.8e-07, Sum P(2) = 1.8e-07
 Identities = 61/224 (27%), Positives = 100/224 (44%)

Query:   208 ESCEKLTHIFSFSISRG--LPQLQTIKVTACKNMKVIFEVGREDDINNTEVIDKIEFSQL 265
             E C  ++ +   + S G  L  + ++ +  C+ +  +FE        N     K  F  +
Sbjct:   692 EGCLAISDVNVSNASIGWLLQHVTSLDLNYCEGLNGMFE--------NLVTKSKSSFVAM 743

Query:   266 RKLTLKSLPQLR--SFCS--VVAFPNLETLKLSAINSETIWH-NQLPAMSSCIQNLTRLI 320
             + L++   P L   S C   +  FPNLE L L  +N E+I   N    M   +Q L  L 
Sbjct:   744 KALSIHYFPSLSLASGCESQLDLFPNLEELSLDNVNLESIGELNGFLGMR--LQKLKLLQ 801

Query:   321 VHGCNNLKFLFSTSLVRSFV-QLQHLEIRKCMDLEGIVFPEEMIEEERKDIVFPQLNFLK 379
             V GC  LK LFS  ++   +  LQ +++  C+ LE +     +  +   + + P+L  +K
Sbjct:   802 VSGCRQLKRLFSDQILAGTLPNLQEIKVVSCLRLEELFNFSSVPVDFCAESLLPKLTVIK 861

Query:   380 MKDLAKLTRFCSGNCIELPSLKQLRMAKCPELKAFILQNINTDM 423
             +K L +L   C+   + L SL+ L +  C  LK       NT M
Sbjct:   862 LKYLPQLRSLCNDRVV-LESLEHLEVESCESLKNLPFVPGNTGM 904


GO:0005634 "nucleus" evidence=ISM
GO:0006952 "defense response" evidence=IEA;ISS
GO:0043531 "ADP binding" evidence=IEA
TAIR|locus:2201996 RPS5 "AT1G12220" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2005517 RPS2 "RESISTANT TO P. SYRINGAE 2" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2034765 AT1G12290 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2197739 AT1G61300 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Fail to connect to STRING server


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 869
PLN032101153 Resistant to P. syringae 6; Provisional 100.0
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 100.0
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.97
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.96
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.89
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.82
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.8
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.71
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.7
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.68
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.67
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.66
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.64
PRK15387788 E3 ubiquitin-protein ligase SspH2; Provisional 99.34
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 99.34
KOG4237498 consensus Extracellular matrix protein slit, conta 99.25
PRK15370754 E3 ubiquitin-protein ligase SlrP; Provisional 99.2
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 99.18
KOG4341483 consensus F-box protein containing LRR [General fu 98.97
KOG4341483 consensus F-box protein containing LRR [General fu 98.96
KOG4237498 consensus Extracellular matrix protein slit, conta 98.93
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 98.92
PF00931287 NB-ARC: NB-ARC domain; InterPro: IPR002182 This is 98.89
KOG0617264 consensus Ras suppressor protein (contains leucine 98.71
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 98.4
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 98.39
KOG0617264 consensus Ras suppressor protein (contains leucine 98.29
PRK15386426 type III secretion protein GogB; Provisional 98.21
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.17
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 98.16
PRK15386426 type III secretion protein GogB; Provisional 98.11
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.09
KOG3207 505 consensus Beta-tubulin folding cofactor E [Posttra 98.02
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 98.0
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 97.98
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 97.89
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 97.71
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 97.66
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 97.47
KOG1947482 consensus Leucine rich repeat proteins, some prote 97.38
KOG1947482 consensus Leucine rich repeat proteins, some prote 97.29
KOG3665699 consensus ZYG-1-like serine/threonine protein kina 97.27
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 97.22
KOG3665699 consensus ZYG-1-like serine/threonine protein kina 97.15
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 97.13
KOG0532722 consensus Leucine-rich repeat (LRR) protein, conta 96.95
KOG0532722 consensus Leucine-rich repeat (LRR) protein, conta 96.81
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 96.18
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 96.05
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 96.01
PLN03150623 hypothetical protein; Provisional 95.64
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 95.59
PLN03150623 hypothetical protein; Provisional 95.53
KOG2982418 consensus Uncharacterized conserved protein [Funct 95.41
KOG2982 418 consensus Uncharacterized conserved protein [Funct 95.35
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 95.1
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 94.4
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 94.35
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 94.14
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 92.49
KOG2123 388 consensus Uncharacterized conserved protein [Funct 92.09
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 92.0
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 91.85
KOG3864221 consensus Uncharacterized conserved protein [Funct 90.72
KOG3864221 consensus Uncharacterized conserved protein [Funct 90.58
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 90.57
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 89.51
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 87.15
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 87.0
KOG2123388 consensus Uncharacterized conserved protein [Funct 86.82
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 81.84
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 80.22
>PLN03210 Resistant to P Back     alignment and domain information
Probab=100.00  E-value=1.3e-35  Score=365.21  Aligned_cols=454  Identities=17%  Similarity=0.212  Sum_probs=305.2

Q ss_pred             CCcchhHHHHhhhcCCChhhHHHHHHHhcCCCccchhhHHHHhhccceecccccCcccccchheecccCCCc--------
Q 040040            1 SPFLALTTITRALKNKSVPEWENVLQELQRPSMKNFQGVLKEACSTIELHYKYLKGEKLKKIFLLCSCHDPT--------   72 (869)
Q Consensus         1 ~~PLAi~~ig~~L~~k~~~~W~~~l~~l~~~~~~~~~~~~~~i~~~L~lSY~~Lp~~~lK~CFlycs~Fped--------   72 (869)
                      |+||||+++|+.|++|+.++|+++++++++..       +.+|.++|++|||+|+++..|.||+|||+||.+        
T Consensus       387 GLPLAl~vlgs~L~~k~~~~W~~~l~~L~~~~-------~~~I~~~L~~SYd~L~~~~~k~~Fl~ia~ff~~~~~~~v~~  459 (1153)
T PLN03210        387 NLPLGLNVLGSYLRGRDKEDWMDMLPRLRNGL-------DGKIEKTLRVSYDGLNNKKDKAIFRHIACLFNGEKVNDIKL  459 (1153)
T ss_pred             CCcHHHHHHHHHHcCCCHHHHHHHHHHHHhCc-------cHHHHHHHHHhhhccCccchhhhhheehhhcCCCCHHHHHH
Confidence            78999999999999999999999999987622       246889999999999865689999999999975        


Q ss_pred             cccchhhhc--------cc-ccc--cccCCCchhHHHHHHhhhccc---------c-hhhhHHH----------------
Q 040040           73 QTCHDIRDS--------AC-PLK--RCLDKPQEKTNDISLKLNASI---------C-LKDKFFT----------------  115 (869)
Q Consensus        73 w~~~g~~~~--------~~-~~~--~~~~~~~~~~r~l~~~~~~~~---------~-~~~~~~~----------------  115 (869)
                      |.+.+..+.        .+ .+.  .....||+.+|+|+.+++..-         . .++.+.+                
T Consensus       460 ~l~~~~~~~~~~l~~L~~ksLi~~~~~~~~MHdLl~~~~r~i~~~~~~~~~~r~~l~~~~di~~vl~~~~g~~~v~~i~l  539 (1153)
T PLN03210        460 LLANSDLDVNIGLKNLVDKSLIHVREDIVEMHSLLQEMGKEIVRAQSNEPGEREFLVDAKDICDVLEDNTGTKKVLGITL  539 (1153)
T ss_pred             HHHhcCCCchhChHHHHhcCCEEEcCCeEEhhhHHHHHHHHHHHhhcCCCCcceeEeCHHHHHHHHHhCcccceeeEEEe
Confidence            333221110        00 111  122468999999998775211         0 0112222                


Q ss_pred             ----------------HhccCceeeecccc--Ccc----ccccccCCCCC-CCccEEEEecCCCceecCCCCCCCCCCCC
Q 040040          116 ----------------QLKGLEELWLDEVQ--GVE----NVVYELDREGF-PSLKLLHIQNNPYLLCINDSTELVPRDAF  172 (869)
Q Consensus       116 ----------------~l~~l~~L~l~~~~--~~~----~~~~~~~~~~~-~~L~~L~l~~~~~l~~i~~~~~~~~~~~~  172 (869)
                                      .+++++.|.+....  ...    .++..+  ..+ ++||.|.+.++ .++.+|..+      .+
T Consensus       540 ~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~--~~lp~~Lr~L~~~~~-~l~~lP~~f------~~  610 (1153)
T PLN03210        540 DIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGF--DYLPPKLRLLRWDKY-PLRCMPSNF------RP  610 (1153)
T ss_pred             ccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcch--hhcCcccEEEEecCC-CCCCCCCcC------Cc
Confidence                            22333333332110  000    001111  111 34566666555 445555443      45


Q ss_pred             CCccEeeccccccccccccccccccccCCCCEEEecCCCCCcccCChhhhcCCCCCcEEEEeecCCceeeeccccccccC
Q 040040          173 PLLESLSLSNLMNLEKISCSQLRAESFLRLRNLKVESCEKLTHIFSFSISRGLPQLQTIKVTACKNMKVIFEVGREDDIN  252 (869)
Q Consensus       173 ~~L~~L~L~~~~~l~~l~~~~~~~~~l~~L~~L~L~~c~~l~~l~~~~~~~~L~~L~~L~l~~c~~l~~l~~~~~~~~~~  252 (869)
                      .+|++|++.++ +++.+|.+   ...+++|++|++++|..++.+|   .++.+++|++|++++|..+..+|         
T Consensus       611 ~~L~~L~L~~s-~l~~L~~~---~~~l~~Lk~L~Ls~~~~l~~ip---~ls~l~~Le~L~L~~c~~L~~lp---------  674 (1153)
T PLN03210        611 ENLVKLQMQGS-KLEKLWDG---VHSLTGLRNIDLRGSKNLKEIP---DLSMATNLETLKLSDCSSLVELP---------  674 (1153)
T ss_pred             cCCcEEECcCc-cccccccc---cccCCCCCEEECCCCCCcCcCC---ccccCCcccEEEecCCCCccccc---------
Confidence            78888998887 67777766   5678999999999888887774   46788999999999998888888         


Q ss_pred             CccccccccCCcccEEeccCCCCcccccccccCCCcCEEEecccc-ccccccCCCCCcccccCCceEEEEecCCCCcccc
Q 040040          253 NTEVIDKIEFSQLRKLTLKSLPQLRSFCSVVAFPNLETLKLSAIN-SETIWHNQLPAMSSCIQNLTRLIVHGCNNLKFLF  331 (869)
Q Consensus       253 ~~~~~~~~~l~~L~~L~l~~~~~l~~~~~~~~l~~L~~L~L~~~~-l~~i~~~~~~~~~~~l~~L~~L~l~~c~~l~~l~  331 (869)
                          ..+..+++|+.|++++|..++.+|....+++|+.|++++|. +..     +|.   ..++|+.|++.++ .++.+ 
T Consensus       675 ----~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~-----~p~---~~~nL~~L~L~~n-~i~~l-  740 (1153)
T PLN03210        675 ----SSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKS-----FPD---ISTNISWLDLDET-AIEEF-  740 (1153)
T ss_pred             ----hhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccc-----ccc---ccCCcCeeecCCC-ccccc-
Confidence                45667889999999999988888877678899999998886 322     232   2457888888775 45554 


Q ss_pred             ChhhHhccCCccEEEEeccccccccccccccccccccccccCccceeecccCccccccCCCcccCCCCccEEEEccCCcc
Q 040040          332 STSLVRSFVQLQHLEIRKCMDLEGIVFPEEMIEEERKDIVFPQLNFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKCPEL  411 (869)
Q Consensus       332 ~~~~~~~L~~L~~L~l~~c~~l~~i~~~~~~~~~~~~~~~~~~L~~L~l~~~~~L~~l~~~~~~~l~~L~~L~l~~c~~l  411 (869)
                      |..  ..+++|++|.+.+|... .+....... .......+++|+.|++++|+.+..+|.. ...+++|+.|++.+|+++
T Consensus       741 P~~--~~l~~L~~L~l~~~~~~-~l~~~~~~l-~~~~~~~~~sL~~L~Ls~n~~l~~lP~s-i~~L~~L~~L~Ls~C~~L  815 (1153)
T PLN03210        741 PSN--LRLENLDELILCEMKSE-KLWERVQPL-TPLMTMLSPSLTRLFLSDIPSLVELPSS-IQNLHKLEHLEIENCINL  815 (1153)
T ss_pred             ccc--ccccccccccccccchh-hcccccccc-chhhhhccccchheeCCCCCCccccChh-hhCCCCCCEEECCCCCCc
Confidence            432  25778888888765421 111000000 0001123578888888888877777754 346788888888888888


Q ss_pred             ccccccccCCCceEeeeeccCcccccccccEEEEeccCCcccccchhHHhhcCCccEEEEcccCCccccccccccCcccc
Q 040040          412 KAFILQNINTDMTVVGIQSFFNEKSFCKLKLMEVIFCKSLWTIFPHNMFARFLKLQSLIVGACGSLEEIFNLQELNSEET  491 (869)
Q Consensus       412 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~c~~l~~~~~~~~~~~l~~L~~L~l~~c~~l~~i~~~~~~~~~~~  491 (869)
                      +.+|..                 ..+++|+.|++++|..+.. +|.    ..++|++|++++ +.++.+|..       +
T Consensus       816 ~~LP~~-----------------~~L~sL~~L~Ls~c~~L~~-~p~----~~~nL~~L~Ls~-n~i~~iP~s-------i  865 (1153)
T PLN03210        816 ETLPTG-----------------INLESLESLDLSGCSRLRT-FPD----ISTNISDLNLSR-TGIEEVPWW-------I  865 (1153)
T ss_pred             CeeCCC-----------------CCccccCEEECCCCCcccc-ccc----cccccCEeECCC-CCCccChHH-------H
Confidence            877743                 1267888888888877754 343    246788888887 566666532       1


Q ss_pred             ccccccccceeecccccccccccccCCCCcccCCCccEEEEecCCCcccc
Q 040040          492 HSGAVSRLRELHVFCLPKLTKIWNKDPRGKLIFPNLVLVRIFECQRLKSI  541 (869)
Q Consensus       492 ~~~~~~~L~~L~l~~~~~L~~l~~~~p~~~~~l~~L~~L~l~~c~~L~~l  541 (869)
                        ..+++|+.|++.+|++|+.+    |..+..+++|+.+++++|++|+.+
T Consensus       866 --~~l~~L~~L~L~~C~~L~~l----~~~~~~L~~L~~L~l~~C~~L~~~  909 (1153)
T PLN03210        866 --EKFSNLSFLDMNGCNNLQRV----SLNISKLKHLETVDFSDCGALTEA  909 (1153)
T ss_pred             --hcCCCCCEEECCCCCCcCcc----CcccccccCCCeeecCCCcccccc
Confidence              36788888888888888887    667777888888888888887755



syringae 6; Provisional

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>PF00931 NB-ARC: NB-ARC domain; InterPro: IPR002182 This is the NB-ARC domain, a novel signalling motif found in bacteria and eukaryotes, shared by plant resistance gene products and regulators of cell death in animals [] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

No homologous structure with e-value below 0.005

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query869
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 8e-14
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 5e-12
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 3e-07
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 7e-07
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 3e-06
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 5e-06
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 1e-05
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 1e-04
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 5e-04
3j0a_A844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-05
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 3e-05
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 8e-05
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 4e-04
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 8e-05
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 1e-04
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-04
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 2e-04
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 3e-04
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 1e-04
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 1e-04
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 3e-04
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 3e-04
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 4e-04
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 5e-04
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 5e-04
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 5e-04
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 5e-04
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
 Score = 74.9 bits (183), Expect = 8e-14
 Identities = 73/504 (14%), Positives = 144/504 (28%), Gaps = 162/504 (32%)

Query: 8   TITRALKNKSVPEWENVLQELQRPS-------MKNFQG--VL-KEACSTIELHYKYLKGE 57
            ++R    +   +    L EL RP+       +    G   +  + C + ++  K     
Sbjct: 130 NVSRL---QPYLKLRQALLEL-RPAKNVLIDGVLGS-GKTWVALDVCLSYKVQCKMDFK- 183

Query: 58  KLKKIFLLC--SCHDPTQT-------CHDIRDSACPLKRCLDKPQEKTNDISLKL----- 103
               IF L   +C+ P           + I  +           + + + I  +L     
Sbjct: 184 ----IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239

Query: 104 -----NASICLKD-------KFF---------TQLKGLEELWLDEVQGVENVVYELD--R 140
                N  + L +         F         T+ K +     D +         LD   
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV----TDFLSAATTTHISLDHHS 295

Query: 141 EGFP---SLKLLHIQNNPYLLCINDSTELVPRDA---FPLLESLSLSNLMNLEKISCSQL 194
                     LL       L  ++   + +PR+     P   S+             ++ 
Sbjct: 296 MTLTPDEVKSLL-------LKYLDCRPQDLPREVLTTNPRRLSI------------IAES 336

Query: 195 RAESFLRLRNLKVESCEKLTHIFSFSISRGLPQLQTIKVTACKNMKVIFEVGREDDINNT 254
             +      N K  +C+KLT I   S++     L+  +     +   +F        +  
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLN----VLEPAEYRKMFDRLSVF----PPSAHIP 388

Query: 255 EVI------DKIEFSQ---LRKLTLKSLPQLRSFCSVVAFPNLETLKLSAINSETIWHNQ 305
            ++      D I+      + KL   SL + +   S ++ P++       + +E   H  
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRS 448

Query: 306 LPAMSSCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRKCMDLEGIVFPEE---- 361
           +                                   + H  I K  D + ++ P      
Sbjct: 449 I-----------------------------------VDHYNIPKTFDSDDLIPPYLDQYF 473

Query: 362 ---------MIEEERKDIVFPQ----LNFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKC 408
                     IE   +  +F        FL+ K +   +   + +   L +L+QL+    
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQK-IRHDSTAWNASGSILNTLQQLKF--- 529

Query: 409 PELKAFILQNINT-DMTVVGIQSF 431
              K +I  N    +  V  I  F
Sbjct: 530 --YKPYICDNDPKYERLVNAILDF 551


>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query869
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 99.97
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 99.97
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 99.97
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.97
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 99.96
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.96
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.96
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.95
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.95
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.95
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.94
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 99.93
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.93
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.93
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.92
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.92
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.92
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.91
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.91
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.9
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.89
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.89
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.89
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.87
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.87
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.87
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.86
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.85
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.84
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.84
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.84
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.83
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.83
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.81
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.81
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.8
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 99.77
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 99.77
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.76
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.75
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.74
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.73
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.72
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.71
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.7
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.69
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.68
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.67
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.67
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.63
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.63
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.63
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.62
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.62
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.61
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.59
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.58
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.58
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.57
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.57
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.56
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.55
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.54
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.53
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.53
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.52
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.52
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.51
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.49
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.45
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.43
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.42
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.42
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.42
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.42
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.41
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.4
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 99.4
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.39
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.37
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.36
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.36
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.33
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.32
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.31
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.3
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.22
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.2
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.18
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 99.17
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.16
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.14
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.12
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.12
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 99.1
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.1
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.08
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.06
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 99.04
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.0
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 98.95
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 98.95
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 98.92
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 98.9
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 98.88
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 98.88
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 98.87
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 98.86
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.86
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 98.83
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 98.81
3e6j_A229 Variable lymphocyte receptor diversity region; var 98.8
3e6j_A229 Variable lymphocyte receptor diversity region; var 98.79
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 98.79
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 98.79
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 98.78
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.76
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.73
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.66
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.64
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.64
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 98.63
2a5y_B549 CED-4; apoptosis; HET: ATP; 2.60A {Caenorhabditis 98.61
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 98.54
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.47
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.41
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.4
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.39
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 98.38
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.38
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.35
4b8c_D727 Glucose-repressible alcohol dehydrogenase transcr 98.34
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 98.33
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 98.29
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 98.26
4b8c_D727 Glucose-repressible alcohol dehydrogenase transcr 98.24
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 98.1
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.02
1vt4_I1221 APAF-1 related killer DARK; drosophila apoptosome, 98.01
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 98.0
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 97.98
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 97.98
3sfz_A1249 APAF-1, apoptotic peptidase activating factor 1; a 97.96
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 97.96
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 97.95
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 97.94
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 97.93
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 97.65
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 97.6
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 97.53
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.49
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 97.42
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 97.38
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 97.37
1z6t_A591 APAF-1, apoptotic protease activating factor 1; ca 97.11
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.01
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 96.73
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 96.62
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 95.36
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 95.09
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 94.41
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 93.75
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 81.85
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 80.38
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
Probab=100.00  E-value=4.8e-35  Score=350.73  Aligned_cols=557  Identities=15%  Similarity=0.044  Sum_probs=363.6

Q ss_pred             CCCCCccEEEEecCCCceecCCCCCCCCCCCCCCccEeeccccccccc-cccccccccccCCCCEEEecCCCCCcccCCh
Q 040040          141 EGFPSLKLLHIQNNPYLLCINDSTELVPRDAFPLLESLSLSNLMNLEK-ISCSQLRAESFLRLRNLKVESCEKLTHIFSF  219 (869)
Q Consensus       141 ~~~~~L~~L~l~~~~~l~~i~~~~~~~~~~~~~~L~~L~L~~~~~l~~-l~~~~~~~~~l~~L~~L~L~~c~~l~~l~~~  219 (869)
                      ..+++|++|+++++.--..++..   .....+++|++|+++++ .+.. .+...  .+.+++|++|++++|. ++..++.
T Consensus        97 ~~l~~L~~L~Ls~n~l~~~~~~~---~~l~~l~~L~~L~Ls~n-~l~~~~~~~~--~~~l~~L~~L~Ls~n~-l~~~~~~  169 (768)
T 3rgz_A           97 KCSASLTSLDLSRNSLSGPVTTL---TSLGSCSGLKFLNVSSN-TLDFPGKVSG--GLKLNSLEVLDLSANS-ISGANVV  169 (768)
T ss_dssp             CCCTTCCEEECCSSEEEEEGGGG---GGGGGCTTCCEEECCSS-EEECCSSCCS--CCCCTTCSEEECCSSC-CEEETHH
T ss_pred             ccCCCCCEEECCCCcCCCcCCCh---HHHhCCCCCCEEECcCC-ccCCcCCHHH--hccCCCCCEEECCCCc-cCCcCCh
Confidence            67888899998887332334431   01257888889988887 3332 22210  1478888999998884 6655431


Q ss_pred             h--hhcCCCCCcEEEEeecCCceeeeccccccccCCccccccccCCcccEEeccCCCCcccccccccCCCcCEEEecccc
Q 040040          220 S--ISRGLPQLQTIKVTACKNMKVIFEVGREDDINNTEVIDKIEFSQLRKLTLKSLPQLRSFCSVVAFPNLETLKLSAIN  297 (869)
Q Consensus       220 ~--~~~~L~~L~~L~l~~c~~l~~l~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~~l~~~~~~~~l~~L~~L~L~~~~  297 (869)
                      .  .++++++|++|++++|.. ....              ....+++|++|+++++.-...++.+..+++|++|++++|.
T Consensus       170 ~~~~~~~l~~L~~L~Ls~n~l-~~~~--------------~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~  234 (768)
T 3rgz_A          170 GWVLSDGCGELKHLAISGNKI-SGDV--------------DVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNK  234 (768)
T ss_dssp             HHHHTTCCTTCCEEECCSSEE-ESCC--------------BCTTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSC
T ss_pred             hhhhhccCCCCCEEECCCCcc-cccC--------------CcccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCc
Confidence            1  167888899998888752 2211              1245888999999887655556667778889999998887


Q ss_pred             ccccccCCCCCcccccCCceEEEEecCCCCccccChhhHhccCCccEEEEecccccc-cccccccccccccccc-ccCcc
Q 040040          298 SETIWHNQLPAMSSCIQNLTRLIVHGCNNLKFLFSTSLVRSFVQLQHLEIRKCMDLE-GIVFPEEMIEEERKDI-VFPQL  375 (869)
Q Consensus       298 l~~i~~~~~~~~~~~l~~L~~L~l~~c~~l~~l~~~~~~~~L~~L~~L~l~~c~~l~-~i~~~~~~~~~~~~~~-~~~~L  375 (869)
                      +...    .|..++.+++|++|++++|..... .|.   ..+++|++|++++|. +. .++..         .. .+++|
T Consensus       235 l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~-~~~---~~l~~L~~L~L~~n~-l~~~ip~~---------~~~~~~~L  296 (768)
T 3rgz_A          235 LSGD----FSRAISTCTELKLLNISSNQFVGP-IPP---LPLKSLQYLSLAENK-FTGEIPDF---------LSGACDTL  296 (768)
T ss_dssp             CCSC----HHHHTTTCSSCCEEECCSSCCEES-CCC---CCCTTCCEEECCSSE-EEESCCCC---------SCTTCTTC
T ss_pred             CCCc----ccHHHhcCCCCCEEECCCCcccCc-cCc---cccCCCCEEECcCCc-cCCccCHH---------HHhhcCcC
Confidence            5432    344455688899999988754333 232   268889999988864 43 33221         22 34889


Q ss_pred             ceeecccCccccccCCCcccCCCCccEEEEccCCccccccccccCCCceEeeeeccCcccccccccEEEEeccCCccccc
Q 040040          376 NFLKMKDLAKLTRFCSGNCIELPSLKQLRMAKCPELKAFILQNINTDMTVVGIQSFFNEKSFCKLKLMEVIFCKSLWTIF  455 (869)
Q Consensus       376 ~~L~l~~~~~L~~l~~~~~~~l~~L~~L~l~~c~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~c~~l~~~~  455 (869)
                      ++|+++++. +..........+++|+.|++.+|.-...+|...               ...+++|++|++++|. +...+
T Consensus       297 ~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~---------------l~~l~~L~~L~Ls~n~-l~~~~  359 (768)
T 3rgz_A          297 TGLDLSGNH-FYGAVPPFFGSCSLLESLALSSNNFSGELPMDT---------------LLKMRGLKVLDLSFNE-FSGEL  359 (768)
T ss_dssp             SEEECCSSE-EEECCCGGGGGCTTCCEEECCSSEEEEECCHHH---------------HTTCTTCCEEECCSSE-EEECC
T ss_pred             CEEECcCCc-CCCccchHHhcCCCccEEECCCCcccCcCCHHH---------------HhcCCCCCEEeCcCCc-cCccc
Confidence            999998886 554433445568889999988764333444210               1236889999998875 44345


Q ss_pred             chhHHhhcC-CccEEEEcccCCccccccccccCccccccccccccceeecccccccccccccCCCCcccCCCccEEEEec
Q 040040          456 PHNMFARFL-KLQSLIVGACGSLEEIFNLQELNSEETHSGAVSRLRELHVFCLPKLTKIWNKDPRGKLIFPNLVLVRIFE  534 (869)
Q Consensus       456 ~~~~~~~l~-~L~~L~l~~c~~l~~i~~~~~~~~~~~~~~~~~~L~~L~l~~~~~L~~l~~~~p~~~~~l~~L~~L~l~~  534 (869)
                      |... ..++ +|++|++++|.....++..       .....+++|++|++++|.--..+    |..+..+++|++|++++
T Consensus       360 p~~l-~~l~~~L~~L~Ls~N~l~~~~~~~-------~~~~~~~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~Ls~  427 (768)
T 3rgz_A          360 PESL-TNLSASLLTLDLSSNNFSGPILPN-------LCQNPKNTLQELYLQNNGFTGKI----PPTLSNCSELVSLHLSF  427 (768)
T ss_dssp             CTTH-HHHTTTCSEEECCSSEEEEECCTT-------TTCSTTCCCCEEECCSSEEEEEC----CGGGGGCTTCCEEECCS
T ss_pred             cHHH-HhhhcCCcEEEccCCCcCCCcChh-------hhhcccCCccEEECCCCcccccc----CHHHhcCCCCCEEECcC
Confidence            6654 4555 8999999986543334321       10013678999999997544444    78899999999999998


Q ss_pred             CCCcccccCccEEEEEeccCCCCCcceeeccccceEeecCCCCCceecCCCCCCCCCCCceeeecc-ccC-cccccccee
Q 040040          535 CQRLKSIFPTSVEIVANDVRGNDAATKFIFPSLTFLKLRDLPYLTTFYSGMHTLECPERANLIFQL-KNP-SFGSKSLVM  612 (869)
Q Consensus       535 c~~L~~l~p~s~ei~~~~~~~~~~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~~~~L~~L~l~~-~l~-~~~~~~~~~  612 (869)
                      | .+....|.++               ..+++|+.|++++|.....++.....  +++|++|++++ ++. .++....  
T Consensus       428 N-~l~~~~p~~l---------------~~l~~L~~L~L~~n~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~p~~l~--  487 (768)
T 3rgz_A          428 N-YLSGTIPSSL---------------GSLSKLRDLKLWLNMLEGEIPQELMY--VKTLETLILDFNDLTGEIPSGLS--  487 (768)
T ss_dssp             S-EEESCCCGGG---------------GGCTTCCEEECCSSCCCSCCCGGGGG--CTTCCEEECCSSCCCSCCCGGGG--
T ss_pred             C-cccCcccHHH---------------hcCCCCCEEECCCCcccCcCCHHHcC--CCCceEEEecCCcccCcCCHHHh--
Confidence            5 5654446544               34789999999998766566655544  48999999998 766 3443221  


Q ss_pred             eEeeecceeccccceeeeecccceeeecc---ccccceEEEe-ecCCCccchHHHHHhccccceEEEE---EE-ecccc-
Q 040040          613 LLCLIGQQVFPNLEELTLSKYIFTTWRQA---QFHKLKILHF-ISDGSDFFQVGLLQNIHNLEKLVLK---VE-EHAEG-  683 (869)
Q Consensus       613 ~~~~~~~~~~~~L~~L~l~~~~~~~~~~~---~~~~L~~L~l-~~~~~~~~p~~~l~~l~~L~~L~l~---~~-~~~~~-  683 (869)
                              .+++|++|++++|.+.+..+.   .+++|++|++ .|...+.+|.. ++.+++|+.|+++   +. ..... 
T Consensus       488 --------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~g~ip~~~  558 (768)
T 3rgz_A          488 --------NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE-LGDCRSLIWLDLNTNLFNGTIPAAM  558 (768)
T ss_dssp             --------GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGG-GGGCTTCCEEECCSSEEESBCCGGG
T ss_pred             --------cCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHH-HcCCCCCCEEECCCCccCCcCChHH
Confidence                    368999999999998865553   3789999999 45555577765 7889999999987   32 11111 


Q ss_pred             --cccccEEEcCc-----------------------------------ccccc------ccccCCCCCcccccCCccEEE
Q 040040          684 --IAQIKSLKLNK-----------------------------------LWFIK------EHLWNPDSKLDSFLQNLEFLE  720 (869)
Q Consensus       684 --~~~L~~L~l~~-----------------------------------~~~L~------~~l~~~~~~~~~~l~~L~~L~  720 (869)
                        ...+..+.+..                                   +..+.      ..+.+..+.....+++|+.|+
T Consensus       559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~Ld  638 (768)
T 3rgz_A          559 FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD  638 (768)
T ss_dssp             GTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEE
T ss_pred             hcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEE
Confidence              11111111110                                   00000      011112233456789999999


Q ss_pred             Eecccchhh-ccccee-EecccchhccccCCCcceeecCCeeeeCCCcceEeeccCCCccccCCCCcCCCcceEEEccCC
Q 040040          721 VKECALSLI-SLRIEI-VFSKLKWLFLESSGSITSFCSGNYAISFPSLEVLIVENCPKLNTFSAGVLKTPRLRAVQNWKL  798 (869)
Q Consensus       721 l~~c~~~l~-~l~~~~-~~~~L~~L~l~~l~~l~~~~~~~~~~~~~~L~~L~i~~c~~~~~~~~~~~~~~~L~~l~~s~~  798 (869)
                      +++|.  +. .+|... .+++|+.|++.++.--..++.  ....+++|+.|++++|......|..+...+.|+.++++.|
T Consensus       639 Ls~N~--l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~--~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N  714 (768)
T 3rgz_A          639 MSYNM--LSGYIPKEIGSMPYLFILNLGHNDISGSIPD--EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN  714 (768)
T ss_dssp             CCSSC--CBSCCCGGGGGCTTCCEEECCSSCCCSCCCG--GGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred             CcCCc--ccccCCHHHhccccCCEEeCcCCccCCCCCh--HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence            99997  65 445442 466677777666432223332  2346789999999999777688998999999999999954


Q ss_pred             C
Q 040040          799 D  799 (869)
Q Consensus       799 ~  799 (869)
                      +
T Consensus       715 ~  715 (768)
T 3rgz_A          715 N  715 (768)
T ss_dssp             E
T ss_pred             c
Confidence            3



>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>2a5y_B CED-4; apoptosis; HET: ATP; 2.60A {Caenorhabditis elegans} SCOP: a.4.5.80 a.77.1.3 c.37.1.20 PDB: 3lqq_A* 3lqr_A* Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>3sfz_A APAF-1, apoptotic peptidase activating factor 1; apoptosis, caspase activation, cytochrome C, procaspase-9, A nucleotide, cytosol; HET: ADP; 3.00A {Mus musculus} PDB: 3shf_A* 3iyt_A* 3iza_A* Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>1z6t_A APAF-1, apoptotic protease activating factor 1; caspase activation, ADP, nucleotide binding, CARD, apoptosis; HET: ADP; 2.21A {Homo sapiens} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

No hit with e-value below 0.005

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query869
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.65
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.63
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.52
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.5
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.41
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.39
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.39
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.35
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.34
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.3
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.3
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.29
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.27
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.21
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.21
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.19
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.19
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.18
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.18
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.17
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.11
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.1
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 98.68
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 98.64
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 98.63
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 98.57
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.39
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.39
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.37
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 98.2
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.15
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 98.0
d2ifga3156 High affinity nerve growth factor receptor, N-term 97.87
d2ifga3156 High affinity nerve growth factor receptor, N-term 97.81
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 97.62
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 97.61
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 94.83
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 94.21
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 88.96
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 86.95
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 84.81
d2a5yb3277 CED-4, NB-ARC domain {Caenorhabditis elegans [TaxI 84.2
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 82.85
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]
Probab=99.65  E-value=1.9e-14  Score=155.24  Aligned_cols=80  Identities=14%  Similarity=0.201  Sum_probs=53.4

Q ss_pred             CCCCccEEEEecCCCceecCCCCCCCCCCCCCCccEeeccccccccccccccccccccCCCCEEEecCCCCCcccCChhh
Q 040040          142 GFPSLKLLHIQNNPYLLCINDSTELVPRDAFPLLESLSLSNLMNLEKISCSQLRAESFLRLRNLKVESCEKLTHIFSFSI  221 (869)
Q Consensus       142 ~~~~L~~L~l~~~~~l~~i~~~~~~~~~~~~~~L~~L~L~~~~~l~~l~~~~~~~~~l~~L~~L~L~~c~~l~~l~~~~~  221 (869)
                      .+.+|++|+++++ +++.+. +     ...+++|++|+++++ ++++++.    .+.+++|++|++++|. ++.++   .
T Consensus        42 ~l~~l~~L~l~~~-~I~~l~-g-----l~~L~nL~~L~Ls~N-~l~~l~~----l~~L~~L~~L~L~~n~-i~~i~---~  105 (384)
T d2omza2          42 DLDQVTTLQADRL-GIKSID-G-----VEYLNNLTQINFSNN-QLTDITP----LKNLTKLVDILMNNNQ-IADIT---P  105 (384)
T ss_dssp             HHTTCCEEECCSS-CCCCCT-T-----GGGCTTCCEEECCSS-CCCCCGG----GTTCTTCCEEECCSSC-CCCCG---G
T ss_pred             HhCCCCEEECCCC-CCCCcc-c-----cccCCCCCEEeCcCC-cCCCCcc----ccCCcccccccccccc-ccccc---c
Confidence            3567888888877 565552 2     246777888888777 5666542    4467778888887774 55553   4


Q ss_pred             hcCCCCCcEEEEeecC
Q 040040          222 SRGLPQLQTIKVTACK  237 (869)
Q Consensus       222 ~~~L~~L~~L~l~~c~  237 (869)
                      ++++++|+.|+++++.
T Consensus       106 l~~l~~L~~L~~~~~~  121 (384)
T d2omza2         106 LANLTNLTGLTLFNNQ  121 (384)
T ss_dssp             GTTCTTCCEEECCSSC
T ss_pred             cccccccccccccccc
Confidence            6677777777776643



>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d2a5yb3 c.37.1.20 (B:109-385) CED-4, NB-ARC domain {Caenorhabditis elegans [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure